SCP
SRDX

Seizert Capital Partners’s Surmodics SRDX Stock Holding History

Seizert Capital Partners’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,786
Closed -$207K – 215
2020
Q2 		$207K Sell
4,786
-3,528
-42% -$134K 0.01% 187
2020
Q1 		$277K Buy
+8,314
New +$300K 0.02% 156

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Seizert Capital Partners's SRDX Position: Q3 2020 in Review

Seizert Capital Partners sold out of Surmodics (SRDX) in Q3 2020, closing a stake of 4,786 shares — an estimated $207K sold.

Seizert Capital Partners first reported a position in SRDX in Q1 2020 and held it in 2 quarters. The position peaked at $277K in Q1 2020. 141 funds tracked by Wall St. Rank hold SRDX as of Q3 2020.

  • Seizert Capital Partners reported no remaining Surmodics position as of Q3 2020 after selling out during the quarter.
  • Seizert Capital Partners sold 4,786 Surmodics shares in Q3 2020, an estimated $207K.
  • Seizert Capital Partners first reported a position in Surmodics in Q1 2020 and held it in 2 quarters.
  • Seizert Capital Partners's Surmodics position peaked at $277K in Q1 2020.
  • 141 funds tracked by Wall St. Rank held Surmodics as of Q3 2020.

Based on Seizert Capital Partners's 13F filing for Q3 2020, filed 3 Nov 2020.